Device Devices

Gore Tag Conformable Thoracic Endoprosthesis

Payments companies reported to CMS as associated with Gore Tag Conformable Thoracic Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$516Kassociated payments (2023-2025)
1,675clinicians with associated payments
1company reporting

By year

2023 $139K
2024 $110K
2025 $267K

Payments reported as associated with Gore Tag Conformable Thoracic Endoprosthesis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $334K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $106K
Surgery $39K
Physician Assistant $5,416
Diagnostic Radiology $3,302
Cardiovascular Disease $2,822

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gore Tag Conformable Thoracic Endoprosthesis

These are the largest totals companies reported as associated with Gore Tag Conformable Thoracic Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Brant Ullery Wilsonville, OR Vascular Surgery $36,345.24
Robert Rhee Brooklyn, NY Vascular Surgery $24,274.24
Evan Brownie Murray, UT Vascular Surgery $19,324.57
Joseph Bavaria Allentown, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $18,291.44
Marvin Atkins Sugar Land, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $17,530.34
Thomas Maldonado New York, NY Vascular Surgery $17,435.75
Dennis Gable Dallas, TX Vascular Surgery $14,338.58
Heron Rodriguez Chicago, IL Vascular Surgery $12,750.00
Ross Milner Chicago, IL Vascular Surgery $10,864.59
Amelia Watkins Palo Alto, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $10,198.00

Prescribed Gore Tag Conformable Thoracic Endoprosthesis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.